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ABSTRACT 
 
Plant secondary metabolism evolved in the context of highly organized and differentiated cells 
and tissues, featuring massive chemical complexity operating under tight environmental, 
developmental and genetic control. Biotechnological demand for natural products has been 
continuously increasing because of their significant value and new applications, mainly as 
pharmaceuticals. Aseptic production systems of plant secondary metabolites have improved 
considerably, constituting an attractive tool for increased, stable and large scale supply of 
valuable molecules. Surprisingly, to date only a few examples including taxol, shikonin, 
berberine and artemisinin, have emerged as success cases of commercial production using this 
strategy. The present review focuses on the main characteristics of plant specialized metabolism 
and their implications for current strategies used to produce secondary compounds in axenic 
cultivation systems. The search for consonance between plant secondary metabolism unique 
features and various in vitro culture systems, including cell, tissue, organ, and engineered 
cultures, as well as heterologous expression in microbial platforms, is discussed. Data to date 
strongly suggest that attaining full potential of these biotechnology production strategies requires 
being able to take advantage of plant specialized metabolism singularities for improved target 
molecule yields and for effective bypassing inherent difficulties in its rational manipulation. 
 
KEYWORDS: Genetically engineered cultures; In vitro culture; Natural products; Secondary 
metabolites; Synthetic biology 
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1. MAIN FEATURES OF PLANT SPECIAL METABOLITES 1 
 2 
 Whereas plant primary metabolites are essential for immediate survival of all plants, being 3 
directly involved in growth, development and reproduction, secondary metabolites (natural 4 
products or specialized metabolites) play a major role in ecology and fitness of a species, often 5 
being restricted to certain taxa, hence the term specialized metabolites.  6 
 Despite progresses in synthetic chemistry, natural products and molecules derived or 7 
modelled from them provided 40% of all drugs approved between 1981-2014 (1). Plants play a 8 
prominent role in the development of this pharmaceutical arsenal. The list of interesting 9 
secondary metabolites is even greater if we include those employed for non-medicinal purposes, 10 
such as chemical industry components, food additives, dyes, perfumes, cosmetics and 11 
nutraceuticals. Plant-derived pharmaceuticals are often expensive, due to difficult or non-12 
economically viable chemical synthesis (2), hard purification from complex extracts, or presence 13 
in low concentrations, sometimes only in rare or endangered species. 14 
 The estimated number of secondary metabolites exceeds 200,000, with terpenes being the 15 
largest class (over 30,000), followed by alkaloids (over 20,000), all of which are produced by 16 
committed biosynthetic pathways (3). In spite of the great number and diversity of structures, 17 
several features are common to most secondary metabolites (Fig. 1), including the generation of 18 
chemical diversity from core compounds through the action of modifying enzymes, such as 19 
hydroxylases, oxygenases, methyltransferases, and glycosyltransferases. The origins of 20 
secondary metabolites, both biosynthetic and evolutionary, stem from primary metabolism. All 21 
secondary metabolites can be traced back to a primary metabolite precursor, hence the term 22 
secondary, and the genes encoding proteins dedicated to secondary metabolism appear to have 23 
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arisen from primary metabolism-related genes by duplication, mutations and subsequent 24 
diversification (4, 5). The cooperation of two or more metabolic pathways is often found in the 25 
biosynthesis of secondary metabolites, such as flavonoids, which depend on both shikimic and 26 
malonic acid pathways to be assembled. Biosynthetic pathways leading to secondary metabolites 27 
can have steps expressed in different tissues or organs.  28 
Biosynthesis of the alkaloid vinblastine requires tissues such as epidermis, parenchyma 29 
idioblasts, laticifers and vascular parenchyma (6). A significant number of secondary metabolites 30 
is produced and/or stored in specialized cell types or structures, including glandular trichomes 31 
and resin ducts. This characteristic is particularly true for lipophilic metabolites, such as terpenes 32 
(7). Different subcellular compartments are often involved in secondary metabolite biosynthesis. 33 
This is the case of bisindole alkaloids production, which requires the involvement of subcellular 34 
compartments as diverse as cytosol, vacuole, chloroplast, nucleus and endoplasmic reticulum (8). 35 
Such complexity of anatomical and subcellular distribution of biochemical pathways adds 36 
another level of regulation to the flux of carbon towards secondary products, i.e. metabolite 37 
transporters (9). In most cases, these transporters are of the ABC-type or H+ - driven. In the 38 
subcellular context, the vacuole often functions as a storage compartment of hydrophilic 39 
secondary metabolites. 40 
 Plant secondary metabolites are frequently modulated by biotic and abiotic signals (10). These 41 
include both herbivore and pathogen attacks, as well exposure to drought, flooding, extreme 42 
temperatures, excess irradiance, UV stress, salinity, and mineral imbalance. Phytohormones and 43 
signaling molecules that mediate adaptive responses to these challenges are also capable of 44 
triggering the accumulation of secondary metabolites. Notable among these are jasmonic acid 45 
and its methyl ester methyl jasmonate, salicylic acid, ethylene, abscisic acid and nitric oxide. 46 
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Accumulation of plant secondary metabolites can be regulated by development and light (11), as 47 
well as by the circadian clock (12).  48 
 Biotic and abiotic stresses generate reactive oxygen and nitrogen species (ROS and NOS), 49 
which trigger secondary metabolite production, accumulation and release. ROS signaling of 50 
secondary metabolism is often a hub in stress responses (13). Since several secondary 51 
metabolites have significant antioxidant properties, their induction by ROS may also contribute 52 
to mitigate the damaging effect of these chemical species on cellular structures and to control 53 
their distribution (14, 15). 54 
 Patterns of secondary metabolite accumulation may be classified in three major types: 55 
constitutive, preformed, and inducible (4). Constitutively accumulated metabolites are present as 56 
basal chemical constituents that often have defense activity against pathogens (16) and 57 
herbivores. This may be the case of phenolic acids and flavonols. The preformed accumulation 58 
often involves vacuolar storage in non-toxic forms that upon physical damage imposed by 59 
herbivores or necrotrophic pathogens, for example, are released and modified to become 60 
bioactive. This is the case of glucosinolates and cyanogenic glucosides, which are stored in 61 
vacuoles and, when released, may form isothiocyanates and cyanide, respectively. Inducible 62 
metabolites are absent or present in low concentrations prior to stress events when their 63 
biosynthesis is activated ensuing accumulation, as is the case of several terpenes and alkaloids. 64 
Many secondary metabolites display combined strategies of accumulation to various extents 65 
(14). 66 
 Enzymes of secondary metabolism are frequently arranged in metabolic channels or 67 
metabolons, physical associations of enzymes organized in membranes of various cellular 68 
compartments. The formation of metabolons is a dynamic process, generally started by 69 
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transmembrane enzymes that act as organizers. As shown for the cyanogenic glucoside dhurrin 70 
of sorghum, the endoplasmic reticulum membrane itself may be part of the metabolon and its 71 
local composition and charge may modulate the channel complex activity (17). These protein-72 
membrane arrangements can also be dismantled and later re-organized, depending on cell 73 
demands. Several advantages are attributed to metabolons, including acceleration of biochemical 74 
reactions, reduced dilution of metabolites, improved flux control coefficient of pathways, easier 75 
metabolic flow of relatively insoluble or unstable intermediates, less undesired effects of toxic 76 
intermediates, facilitated allocation of metabolites to appropriate storage compartments, and 77 
improved metabolic cross-talk and redirection (18). 78 
 Physical organization in close proximity is not only observed for enzymes involved in plant 79 
secondary metabolism, but it is also found at the genome level. Clusters of related genes 80 
involved in biosynthesis of several classes of secondary metabolites (terpenes, alkaloids, 81 
benzoxazinoids and cyanogenic glucosides) resembling prokaryotic operons have been described 82 
(19). Secondary metabolism gene clusters most likely originated from primary metabolism genes 83 
(20). Clusters include regulatory sequences, promoters, coding sequences, and intergenic 84 
regions, making possible the design of minimum regulatory clusters (21). Transcription factors 85 
controlling gene clusters can lie outside their structure. Cluster arrangement may facilitate co-86 
expression, coinheritance, assembly of metabolic channels, and regulatory chromatin changes 87 
(20). 88 
 The complexity and peculiar features of secondary metabolite biosynthesis and homeostasis 89 
as outlined above make producing them in reproducible, controlled and scalable fashion a hard 90 
task. Nonetheless, there are a number of cultivation strategies to obtain metabolites of interest, 91 
using wild types or genetically modified versions of whole plants, axenic cultures of cells, organs 92 
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and microorganisms expressing plant genes, as well as chemical syntheses or semi-synthesis. In 93 
fact, although cell cultures can present low yields, genetic and biochemical instability (22), there 94 
are notable cases of success, such as the production of taxol, ginsenosides, and the red dye 95 
shikonin. Next, basic aspects affecting aseptic biological production systems of natural products, 96 
including recent key examples of synthetic biology strategies, will be discussed. Techniques that 97 
properly consider specific features of secondary metabolism, or are even designed to take 98 
advantage from them, may provide important solutions for producing compounds of economic 99 
interest.  100 
 101 
2. ASEPTIC CULTIVATION BASED SOLUTIONS FOR PRODUCING BIOACTIVE 102 
METABOLITES 103 
 104 
 Under the right set of conditions, plant cultivation in field or greenhouse environment can be 105 
advantageous over axenic production systems, particularly when compound market value is not 106 
sufficiently high to make the latter approach commercially attractive. However, extraction from 107 
plants has some drawbacks, such as climate dependence, susceptibility to pathogens, poor 108 
adaptation to grow in dense monocultures, specific requirements of fertilizers and agrochemicals, 109 
logistics, and regulatory issues for field deployment of genetically modified plants. Wild plant 110 
genetic heterogeneity can impact on product quality and the need for extensive purification steps 111 
to obtain the active molecules from largely impure extracts increases costs and chemical 112 
residues.  113 
 A range of complementary solutions for the production of bioactive metabolites is available 114 
(23, 24). The techniques range from in vitro callus and cell suspension cultures, immobilized 115 
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cells, root and shoot cultures, hairy roots, whole plant liquid cultures, micropropagation 116 
techniques, and plant cell catalyzed biotransformation. These strategies may involve genetically 117 
transformed cell lines with engineered metabolic pathways in homologous or heterologous plant 118 
species, as well as microorganisms, which facilitate production scale up (Fig. 2). Cell suspension 119 
cultures and immobilized cells can also be used to produce target compounds. Cell cultures have 120 
an unlimited potential for growth and plant regeneration. 121 
 122 
2.1 Plant cell cultures  123 
 124 
 Suspension cultures are fast growing and amenable to continuous culturing in a chemostat 125 
vessel. Plant cells are biosynthetically totipotent for each cell is potentially able to produce the 126 
range of chemicals found in the parent plant. Plant cell culture has three main uses: production of 127 
secondary metabolites, biomass generation, and basic studies (25-27). Cell cultures are a 128 
continuous source of natural products (25, 28, 29). Growth conditions, e.g. temperature, pH, light 129 
quality and quantity, phytohormones, aeration, agitation, immobilization, as well as the medium 130 
composition, can be manipulated in order to optimize the production of the desired metabolites 131 
(25, 30-33). 132 
Several secondary metabolites accumulate during stationary phase of growth. At this stage, 133 
carbon allocation for primary metabolism is reduced, so secondary compounds are more actively 134 
synthesized. It has been frequently observed that many new enzymatic activities appear during 135 
stationary phase, suggesting biochemical differentiation of cells (34). In cell cultures, secondary 136 
metabolites can be produced under controlled conditions. High yielding cell selection, product 137 
harvest, validation, and extraction are facilitated and less costly. Cell banks may be preserved at 138 
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low temperatures for long periods and genetically modified cells can be grown in a contained 139 
environment. Some metabolites in plant cell cultures may accumulate at higher titer in cell 140 
cultures compared to the parent plants (35), and cell cultures may be also be a source of new 141 
chemical diversity.  142 
Undifferentiated cultures can undergo significant somaclonal variation, usually after several 143 
subculture cycles, leading to variable production of secondary metabolites. After a certain period 144 
of time (ranging from weeks to years), genetic stability is often achieved and the culture can be 145 
regarded as homogeneous (34). On the other hand, somaclonal variation may be a useful source 146 
of variability to explore in terms of biosynthetic capacity. However, plant cell cultures frequently 147 
yield low quantities of target metabolites and entail high costs. These constraints are of less 148 
importance if the target metabolite has a high market value, and if the costs of culture media, 149 
precursors and elicitors are kept low.  Some basic conditions need to be achieved: high yields of 150 
compound(s), high growth rates, and amenability to scale up. 151 
An emblematic case is taxol (paclitaxel) production by Taxus cell cultures (Fig. 3). Taxol is 152 
considered one of the most important anticancer drugs of the last few decades. Its antitumor 153 
activity is due to microtubule stabilization (36). Production of taxol by calli, immobilized and 154 
suspension cells of T. cuspidata and T. canadensis in completely defined media showed the 155 
feasibility of cell culture as source of this drug (37). Cultures of other Taxus species were also 156 
shown to produce taxol, while further improvement of taxol yield from cell cultures was 157 
achieved by precursor feeding (e.g. phenylalanine) and jasmonate elicitation (38, 39). Additional 158 
key improvements were reached by employing a two-stage culture system, elicitation with 159 
MeJA, immobilization in alginate beads and scaling up in stirred bioreactor (40, 41). Taxus 160 
media cells have been engineered to express taxadiene synthase gene, encoding the enzyme 161 
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catalyzing the first committed step in taxol biosynthesis, yielding higher taxane production (42). 162 
Currently, cell culture brought to industrial scale is one of the major commercial sources of high 163 
quality taxol (http://www.phytonbiotech.com/ access October 16th, 2017). 164 
 On the other hand, as a result of the presence of high concentration of carbohydrates and 165 
auxins in culture medium, cells show relatively fast growth rates, but low expression of 166 
secondary metabolic pathways. This common condition may be a function of various factors, 167 
such as competition for common precursors, inadequate metabolite storage in vacuoles, poor 168 
compartmentation of enzyme and intermediates, nonfunctional plastids, low expression of 169 
enzymes and regulatory proteins (15, 43). Problems in the normal function of small RNAs (44) 170 
and selective proteolysis systems may also contribute to the unfavorable biochemical phenotype 171 
that leads to low yields of metabolites of interest in some cell cultures. As discussed in previous 172 
sections, considering the strong dependence of secondary pathways on subcellular 173 
compartments, different cell types, tissues and even organs to fully operate in plants, it is not 174 
surprising that relatively disorganized cultures often fall short of providing attractive yields of 175 
target molecules. To overcome or alleviate this constraint, a number of strategies can be 176 
implemented. Essentially these approaches have explored the responsiveness of secondary 177 
metabolism to specific environmental stimuli and associated signaling molecules, dependence on 178 
primary metabolite precursors, frequent inverse relationship with growth, and partial recovery of 179 
tissue-like condition. 180 
 181 
2.2 Common strategies to increase secondary metabolite production in plant cell cultures 182 
 183 
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 Selection and optimization of cell lines may increase the productivity of a given process by 184 
several orders of magnitude. Cell line selection for callus induction to obtain high-producing cell 185 
lines can begin with the choice of an elite parent plant. Cell cultures are heterogeneous 186 
populations with different physiology, requiring screening for variant cell clones containing the 187 
highest levels of desired product. This has been exploited with cinnamic acid derivatives, 188 
anthraquinones, berberines, shikonins and anthocyanins ((Maschke, Geipel and Bley (25), 189 
Fischer, Vasilev, Twyman and Schillberg (28)). An inverse relationship between mean cell 190 
aggregate size and taxol yield has been described, pointing out to the potential importance of this 191 
parameter in developing elite cell cultures (45). On the other hand, immobilized cultures may 192 
create a pseudo-tissue condition, in which a certain degree of differentiation is recovered and 193 
new molecule gradients are established. Mutation strategies have been employed in order to 194 
obtain cells overproducing secondary metabolites. Selective agents (such as p-195 
fluorophenylalanine, 5-methyltryptophan, glyphosate and biotin) have been tested to select high 196 
yielding cell lines. In this method, a large population of cells is exposed to sublethal doses of a 197 
toxic (or cytotoxic) metabolic inhibitor or an environmental stress, selecting resistant cells, 198 
which may overproduce target molecules or their precursors (25, 46).  199 
 Media optimization determines the appropriate amounts and ratios of key nutrients, which 200 
affect the supply of precursors and energy, playing a crucial role in production of secondary 201 
metabolites (47). The common dichotomy between growth and secondary metabolism led to 202 
two-stage culture systems, involving an initial growth stage, to generate a large amount of 203 
biomass and a second stage, when the media is depleted of growth stimulants such as nitrate, 204 
phosphate and growth regulators, while sometimes also increasing carbon supply. Metabolite 205 
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accumulation can be modulated by the concentration and nature of the inorganic and organic 206 
components and phytohormones (27, 28). 207 
 Supplying a precursor compound (preferably cheap and available) of a secondary metabolite 208 
biosynthetic pathway can increase the yield of the final product. Higher production of secondary 209 
metabolites upon supplying precursor or intermediate compounds has been frequently noted. 210 
Feeding L-phenylalanine or benzoic acid to Taxus suspension cultures, for example, increased 211 
taxol yield (48, 49). 212 
 Contents of secondary metabolites fluctuate during development (e.g. (Fait, Hanhineva, 213 
Beleggia, Dai, Rogachev, Nikiforova, Fernie and Aharoni (50), Ayan, Çirak and Yanar (51)). 214 
Regulation of secondary metabolic pathways is considered an integral part of plant development 215 
(52). An ‘elicitor’ may be defined as a substance initiating or improving biosynthesis of specific 216 
compound(s) when introduced in small concentrations. Elicitors can be classified on the basis of 217 
their ‘nature’ as abiotic or biotic, and on the basis their ‘origin’ as exogenous or endogenous.  218 
 Production of secondary metabolites can be enhanced by the treatment of undifferentiated 219 
cells with abiotic or biotic elicitors. Stress factors, such as osmotic shock, heavy metal ions, 220 
inorganic salts, methyl jasmonate, salicylic acid, nitric oxide, chitosan, chitin and bacterial, 221 
fungal and yeast homogenates, cyclodextrins, temperature changes or UV radiation, may 222 
enhance secondary metabolite accumulation (53-55). Elicitation was effective, for example, in 223 
stimulating production of taxol by Taxus cell suspension cultures, ajmalicine by Catharanthus 224 
roseus, and tropane alkaloids by suspension cultures of Datura stramonium. This strategy, in 225 
conjunction with end-product removal and accumulation in an extractive phase, has proven to be 226 
very successful for increasing yields. Two-phase operation with elicitation-enhanced alkaloid 227 
production in cell suspension cultures of Eschscholzia californica was also developed (35, 56). 228 
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Jasmonic acid, its active conjugate jasmonoyl-isoleucine, and related molecules have proven to 229 
be of particular importance in the elicitation of most secondary metabolites studied so far (57), 230 
suggesting it may be a signaling hub in transduction pathways leading to activation of 231 
specialized metabolism. 232 
 Many interesting compounds are produced in roots or shoots, but not in suspension cultures, 233 
e.g. hyoscyamine and digoxin, respectively, wherein a certain degree of differentiation is 234 
necessary for the expression of the appropriate biosynthetic pathway. As discussed above, the 235 
need for specialized tissues and cells with particular cellular environments and subcellular 236 
differentiation, coordinated transport of intermediates and split-pathway expression patterns are a 237 
common feature of secondary metabolism. When biosynthesis of a certain compound does not 238 
occur in cell culture, use of shoot, root or whole plant cultures may be an alternative. 239 
 240 
2.3 Production of secondary metabolites in differentiated cultures 241 
 242 
 Differentiated cultures are genetically more stable than cell cultures. Hyoscyamine and 243 
scopolamine are obtained from root cultures, whereas essential oils, morphinan alkaloids of 244 
Papaver somniferum and sesquiterpene lactones (artemisinin) of Artemisia annua, in shoot 245 
cultures (27, 53, 55, 58). Valepotriates from Valeriana glechomifolia have been successfully 246 
produced by whole plant liquid cultures in floating rafts (59). 247 
 Adventitious root cultures, normally induced by phytohormones in medium (in many cases by 248 
high auxin concentrations), are amenable to biotechnological applications due to availability of 249 
root-specific bioreactors, possibility of becoming autotrophic (through manipulation of light, 250 
CO2, and carbohydrate supply), and a natural capacity of secreting metabolites. Production of 251 
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secondary metabolites from adventitious root cultures involves various stages, resembling those 252 
of cell cultures. Adventitious root cultures have been successfully used for producing essentially 253 
all classes of secondary metabolites. Medium optimization, elicitation and precursor feeding 254 
have been used for enhancing metabolite yields in adventitious root cultures of Bupleurum 255 
falcatum, Echinacea spp., Hyoscyamus niger, Panax ginseng, Scopolia parviflora, Withania 256 
somnifera, and Polygonum multiflorum (47, 60). 257 
 Shoots exhibit some properties comparable to roots, namely genetic stability, good 258 
competence for secondary metabolism, and possibility of positive growth-production correlation. 259 
Shoots and somatic embryos may be grown in bioreactors for metabolite production and/or 260 
clonal mass propagation. However, there are some differences in the metabolic pattern, as some 261 
pathways are specifically expressed in either roots or shoots. Other differences concern a 262 
somewhat slower growth rate (fastest doubling time circa 3 days), and light requirements (61-263 
63). 264 
 Further improvement of target metabolite yields either in cell cultures or in differentiated 265 
cultures can be attained by genetic modification. This strategy may also be used to overcome 266 
limitations of production of specific culture systems or species. Metabolic engineering may focus 267 
on biosynthetic, transporter or regulatory genes using generic or tissue/cell specific promoter 268 
sequences. Such spatial specificity may improve target metabolite yields by mimicking the 269 
natural distribution conditions of secondary metabolic pathways in whole plants and 270 
differentiated cells, potentially optimizing enzyme activity by providing appropriate 271 
microenvironmental conditions and cofactor/activator supply. 272 
 273 
2.4 Genetically modified cultures for the production of bioactive compounds 274 
14 
 
 275 
 The complex and puzzling molecular/ biochemical/cellular regulatory scenario of secondary 276 
metabolism poses a formidable challenge for metabolic engineers, particularly in the case of cell 277 
cultures. Nevertheless, there are examples of successful modification of secondary metabolic 278 
pathways, leading to desired metabolic profiles (64). Overall, there seems to be no single recipe 279 
for success, the degree of which may vary on an individual basis. Some strategies, however, 280 
appear to be more likely to yield the expected results. 281 
 The interruption of the expression of end portions of pathways through the use of antisense or 282 
RNAi technology has been applied in an effort to increase the accumulation of upstream 283 
metabolites. Insertion of single reaction steps or short side pathways that draw on abundant 284 
intermediates of the original pathway or a combination of the first two strategies just outlined 285 
may also be useful. Particular attention was given to the adequate supply of enzyme cofactors 286 
and systems for their regeneration, so increased enzyme activity is not compromised at the post-287 
translational level (65). The introduction of feedback insensitive forms of enzymes with 288 
significant input on metabolic flux control has been effective for increasing the yields of some 289 
metabolites of early parts of pathway(s). Similarly, the introduction of transporters to shuttle 290 
final metabolites into the vacuole, causing a relief of feedback inhibition, can be a means to 291 
improve metabolite yield.  292 
 One of the most promising approaches to engineer secondary metabolic pathways has been 293 
based on the modification of expression of transcription factors that control biosynthetic enzyme 294 
genes. In theory, this ensures a relatively coordinated and almost 'stoichiometric' production of 295 
enzymes, allowing for optimized biosynthesis. The efficiency of this approach is justified by the 296 
systemic nature of biochemical pathways (metabolic flux control) (66). The introduction of novel 297 
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secondary pathways in host cells or plants is often effective, suggesting that primary metabolite 298 
precursors may not be rate limiting. The expression of Arabidopsis genes leading to 299 
benzylglucosinolates in tobacco plants was successfully accomplished by employing USER™ 300 
Cloning and USER™ Fusion, a versatile ligation-free technique based on uracil excision that 301 
allows cloning of large fragments of DNA (up to a few kb) (67, 68). 302 
 Various transcription factors regulating the expression of genes encoding secondary 303 
metabolism enzymes are modulated by jasmonate. Examples include ORCA (terpenoid indole 304 
alkaloids), ERF (nicotine and artemisinin), MYC2 (indole glucosinolates, alkaloids and 305 
anthocyanins), MYB (phenylpropanoids, alyphatic glucosinolates), WRKY (terpenes and 306 
alkaloids) (69). Not surprisingly, jasmonate and its derivatives are some of the most powerful 307 
and widely used stimulators of secondary metabolite production in biotechnological applications. 308 
The genetic manipulation of the jasmonate signaling pathway in plants may lead to new insights 309 
on the production of valuable metabolites. 310 
 Because of the complex morphology of plant cells and tissues, compartmentalization must be 311 
taken into account in attempts to modify metabolic pathways. Plant cell function is the result of 312 
elaborate interactions involving the genomes of chloroplasts, mitochondria and nucleus (70). As 313 
it has been established for flavonoid and monoterpene indole alkaloid metabolism, portions of 314 
secondary pathways can be distributed between cytosol, endoplasmic reticulum, chloroplast, 315 
vacuole, and nucleus (71, 72). Effective modification of secondary metabolic pathways demands 316 
targeting of introduced genes to the correct compartment. This ensures the adequate cell 317 
microenvironment for enzyme activity and promotes correct balance of precursors and products 318 
in the pathway (73). Hence, constructs for gene introduction should consider sequences encoding 319 
target peptides. 320 
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 The use of chloroplast genomes to express introduced genes can be advantageous to achieve 321 
higher expression levels. Since chloroplasts are abundant in several cell types, particularly in leaf 322 
mesophyll tissues, and each chloroplast has multiple copies of its genome, the effect of the 323 
overall copy number of introduced genes per cell after transplastome selection becomes relevant. 324 
In addition, as a rule, chloroplast genomes are of typical prokaryotic structure, made of circular 325 
double stranded sequences with very constant gene composition and relative positioning, 326 
allowing easy integration in specific regions by homologous recombination, as well as the 327 
introduction of gene clusters or synthetic multigene operons (74). Modifications introduced in 328 
the nuclear genome, on the other hand, are not so readily directed to specific positions. However, 329 
significant progress in site specific gene insertion/modification in the nuclear genome can be 330 
obtained by CRISPR/Cas technology, which takes advantage of components of the DNA 331 
repairing machinery (75). 332 
 Cell, tissue and organ specific promoters can be used to control metabolism through gene 333 
expression in specific locations, thereby avoiding pitfalls of ectopic expression and metabolic 334 
energy waste. Terminally differentiated cell-specific promoters associated with glandular 335 
trichomes, secretory resin ducts, root hairs and stomata guard cells are potential tools to direct 336 
expression to certain cells only. Root, shoot, fruit, seed, and flower-specific promoters are also 337 
available from various well characterized genes, as well as tissue specific promoters, such as 338 
vascular tissue-related, for example. Various databases and software packages are available for 339 
analyzing plant promoter sequences to find conserved cis elements and transcription factor 340 
binding sites, including combinatorial cis-regulatory regions (76). Temporally regulated 341 
expression may be attained by using promoters associated with developmental phases, such as 342 
senescence, flowering, fruit maturation, and promoter elements of clock regulated genes, e.g. 343 
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morning or evening specific cis elements for gene expression (77-80).  344 
 Alternatives exist for inducible promoters, such as responsiveness to chemicals (e.g. ethanol 345 
or pathogen elicitors), light or phytohormone responsive elements. The introduction of 346 
appropriate responsive elements in the transgene promoter construct may render the expression 347 
sensitive to drought, salinity, osmotic, UV exposure and other abiotic stresses. These are 348 
conditions that often lead to secondary metabolite accumulation (81, 82). 349 
 Combined overexpression of biosynthetic genes regulated by glucocorticoid-inducible 350 
promoter increased production of various monomeric indole alkaloids; however, single gene 351 
overexpression induced some monomeric indole alkaloids, while inhibiting the accumulation of 352 
others. These data indicate the need for overexpressing multiple genes to enhance metabolic flux 353 
toward late products of the pathway (83).  354 
  Overexpression of the transcription factor ORCA3, which regulates the expression of various 355 
monoterpene indole alkaloid biosynthetic genes, and of the terpene moiety-related enzyme 356 
geraniol 10 hydroxylase (G10H), whose transcription is not regulated by ORCA3, was attempted 357 
to improve accumulation of dimeric indole (bisindole) alkaloids in hairy roots and plants of 358 
Catharanthus roseus (84). In cell cultures, overexpression of ORCA3 lead to an increase in total 359 
alkaloids, but, due to lack of production of vindoline, no dimeric alkaloids, such as vinblastine, 360 
accumulated. This result probably reflected the need for tissue differentiation to achieve full 361 
biosynthesis.  362 
 Monomeric catharantine and vindoline are coupled to form antitumor dimeric alkaloids. 363 
Catharantine is secreted to the leaf surface, apparently for defense against pathogens, whereas 364 
vindoline would be released from cells upon herbivore damage, then allowing dimeric alkaloid 365 
biosynthesis. Viral-induced gene silencing of an epidermal ATP-binding cassete catharantine 366 
18 
 
transporter (CrTPT2) of Catharanthus plants increased intracellular contents of catharantine, 367 
thereby leading to higher concentration of dimeric alkaloids of pharmaceutical value in leaves 368 
(85). Engineering plant secondary metabolite transporters may become a valuable technology for 369 
improving yields, including in heterologous microbial platforms (86). 370 
 Clearly, the tool kit to genetically engineer secondary metabolism pathways leading to 371 
valuable metabolites is continuously expanding and improving. Among the simplest and most 372 
widely used genetically altered cultures to produce bioactive secondary metabolites are hairy 373 
roots. 374 
 375 
2.5 Features of hairy roots 376 
 377 
 Hairy roots, also called transformed roots, are formed as a result of infection with 378 
Agrobacterium rhizogenes, a soil borne bacterium responsible for the hairy root disease in a 379 
number of dicots (87). Hairy roots show extensive branching and rapid plagiotropic growth on 380 
hormone-free medium (88). Hairy root cultures show similar or even higher biosynthetic 381 
capacity of secondary metabolite production compared to mother plants, as well as higher 382 
genetic and biochemical stability compared to conventional root cultures (89). Hairy roots have 383 
been used for obtaining stable transgenic plants, large scale production of bioactive compounds, 384 
plant regeneration and functional analysis of genes, to study plant-pathogen and plant-symbiont 385 
interactions, expression of recombinant proteins, and phytoremediation (61, 90-96). Hairy roots 386 
are widely used to investigate regulation of plant secondary metabolism in organized cultures. 387 
Metabolic engineering tools have made hairy root cultures amenable to introduction of 388 
transgenes and thus to genetic modification of their metabolic pathways (97, 98). 389 
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 Hairy root cultures have been used for the production of ajmalicine in Catharanthus roseus 390 
(99), ginsenosides in Panax ginseng (100), tropane alkaloids in Datura metel, Duboisia sp. and 391 
Hyoscyamus sp. (100, 101), withanolides in Withania coagulans (102), and artemisinin of 392 
Artemisia annua (103). In this last study, a combined cultivation in submerged liquid phase 393 
growth stage followed by gas-phase step in nutrient mist reactor was the most effective of three 394 
bioreactor types tested. Sesquiterpene production in this set up could have been influenced by the 395 
inherent stress conditions of liquid to gas phase shift. Ginsenoside production in hairy root 396 
cultures of Panax ginseng was successfully scaled up to bioreactor level, achieving productivity 397 
almost 2-fold higher than in small flasks (104). 398 
 The in vitro transformation of plant material with Agrobacterium rhizogenes involves 399 
chemotactism of Agrobacterium towards the plant cells, binding of bacteria to the surface 400 
components of the cell wall, activation of virulence (vir) genes, transfer and integration of the 401 
transfer-DNA (T-DNA) into the plant genome. T-DNA of Ri plasmid contains multiple open 402 
reading frames (ORFs) (105). As a result of transformation, the metabolism of plant cells is 403 
changed and hairy roots are formed. 404 
 Several factors can affect efficiency of transformation to develop hairy roots. Both plant and 405 
bacterial aspects play roles in the process. Bacterial factors include A. rhizogenes strain, culture 406 
medium and selection of antibiotic for elimination after co-cultivation. Plant factors involve 407 
species, ecotypes, explant type, developmental stage, and growth rate. To attain optimum results 408 
of transformation both microorganism and plant factors must be evaluated on a case-by-case 409 
basis (106, 107). 410 
 In several plant species, higher amounts of bioactive compounds in hairy roots have been 411 
reported when compared to the mother plants. Moreover, progress in scale-up of hairy root 412 
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cultures for biomass and secondary metabolites production has made this system a useful tool for 413 
industrial applications (108, 109). 414 
 T-DNA of A. rhizogenes is known to activate the synthesis of secondary metabolites in 415 
transformed plant cells (110). The potential of hairy roots for production of various bioactive 416 
compounds has been well documented. A. rhizogenes mediated transformation of plants may be 417 
used similarly to A. tumefaciens methods. However, hairy roots originate from single cells and 418 
are comprised only of transformed cells, whereas tumors induced by A. tumefaciens encompass a 419 
chimera of transformed and non-transformed cells. 420 
 Roots of Atropa belladonna engineered with A. rhizogenes carrying 6-hydroxylase gene of 421 
Hyoscyamus muticus were observed to produce five-fold higher concentration of scopolamine 422 
(98). Hairy roots induced by genetic transformation of A. rhizogenes or its regenerated plants 423 
have been successfully used for the production of several pharmaceutical or aromatic 424 
compounds. Rol genes from A. rhizogenes proved to be potential activators of secondary 425 
metabolism in transformed cells, possibly by turning on defense genes (93, 111). 426 
 In spite of its regulatory complexity, plant specialized metabolism can be engineered in host 427 
organisms such as other plant species, bacteria and yeast. Expression in heterologous plant 428 
species is somewhat facilitated by the presence of several primary metabolism pathways to 429 
support specialized target molecules, as well as by well-established transformation protocols for 430 
model systems. On the other hand, limitations may arise from the lack of terminally 431 
differentiated cell types required for proper biosynthesis and end product storage, such as 432 
secretory ducts and glandular trichomes.  433 
 From a biotechnological perspective, the expression of plant specialized metabolites in 434 
microbes is a great asset since it provides a simplified platform for scale up and mass production. 435 
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Although at first it may seem unlikely to succeed, the transfer of plant secondary metabolic 436 
pathways to bacteria and yeast is not that far from the cellular scenario in which this particular 437 
type of metabolism evolved. The presence of gene clusters resembles the physical organization 438 
of bacterial operons, yeast metabolons are essentially similar to those of plants, and so is the 439 
presence of vacuoles, key cellular compartments shared by fungi and plants. Combining the 440 
expression of transporters, the use of appropriate inducible promoters and metabolic inhibitors, 441 
synthetic biology for producing important classes of plant secondary metabolites has been 442 
successfully accomplished in bacteria and yeast. Next, a brief description of some representative 443 
examples of ingenious ways to produce special plant metabolites in microbes is presented. 444 
 445 
3. MICROBIAL PLATFORMS FOR EXPRESSING PLANT PATHWAYS 446 
 447 
 Metabolic engineering can reconstitute plant metabolic pathways in heterologous systems, 448 
mostly bacteria, yeasts or other plant species. In the first two cases, a simpler, robust and 449 
amenable to scale up organism is sought, whereas in the case of other plant species easier 450 
cultivation and genetic transformation, as well as faster growth, are the driving reasons for 451 
applying this strategy. In heterologous plant species, common early precursors may be readily 452 
available, often simplifying matters. Microbial production of secondary metabolites of interest 453 
may facilitate purification processes, since there are relatively less contaminating compounds 454 
compared to plant cells. Although cost-effectiveness to produce fine biochemicals using plants is 455 
attractive, demanding basically sunlight, carbon dioxide, water and soil, microbial cultures may 456 
be grown using as nutrient sources low cost abundant feedstock biomass.  457 
Structure and physico-chemical properties of the product of interest, host codon usage 458 
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preference, requirements for post-translational modifications in biosynthetic or regulatory 459 
proteins (glycosylation, farnesylation), precursor availability, requirements for subcellular 460 
compartments, and effective strategies for host genetic transformation are some relevant aspects 461 
to consider in selecting a microbial platform to express plant pathways (65). The selection of an 462 
appropriate microbial host may also depend on the desired strategy of engineering (64). Pre-463 
existing pathways present in the microbe may be modified to accommodate parts of plant 464 
metabolic catalytic steps or an entire new pathway may be introduced. Exogenous precursor 465 
supply may further stimulate activity of introduced pathways. Host strain optimization is often a 466 
crucial aspect to achieve higher yields. Combined inhibition of competitive endogenous 467 
pathways and expression of plant genes encoding target metabolite biosynthesis in regulated 468 
fashion by means of inducible promoters is an interesting strategy. Production of artemisinic acid 469 
at 25g.L-1 in yeast and semi-synthesis of the antimalaric chemotherapeutic artemisinin used this 470 
approach (112). Expression of enzymes of different sources (plants, fungi, animals and bacteria) 471 
and improvement of catalytic activity by enzyme engineering may also be useful in yeast hosts 472 
(113). 473 
 In any of the scenarios just outlined, a demand for general precursors is often present. To 474 
minimize this bottleneck, the catalytic steps leading to general precursors in higher demand may 475 
be duplicated or specific enzymes with higher input in the metabolic flux control can be 476 
overexpressed. Extra copies of enzymes may be introduced with modifications so as to operate in 477 
a different subcellular context (e.g. conventional membrane bound and simplified soluble form) 478 
(114). 479 
Examples of molecules of interest produced in engineered microbes include taxadiene (taxol 480 
precursor) (115), artemisinic acid (artemisinin precursor) (112), S-scoulerine (berberine 481 
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precursor), 8-hydroxycadinene (gossypol precursor), resveratrol (116), and opioids, such as 482 
thebaine and hydrocodone (113). Ingenious strategies have been used to introduce biosynthetic 483 
gene clusters using episomal type expression vectors in microorganisms. A combination of SOE-484 
PCR (Splicing by Overlap Extension Polymerase Chain Reaction) and in vitro homologous 485 
recombination was used for the expression of early steps of taxol biosynthesis in yeast (115).  486 
Cell-free systems have also been considered as alternatives for expressing biochemical 487 
pathways leading to metabolites of interest. Although in relatively early stage of development for 488 
plant secondary metabolites, these systems rely essentially on matrix immobilized enzymes, 489 
scaffold protein co-expressed pathways optimized for enzyme titer, or artificial cell-type 490 
structures, such as lipid and foam vesicles (114). In line with these strategies, the use of ionic 491 
liquids for maintaining immobilized or free enzymes or, depending on toxicity levels, for 492 
cultivating plant or microbial cells, may also prove useful (117). 493 
 494 
CONCLUSION 495 
 496 
 Plant aseptic cultures are complementary tools for the production of bioactive and other 497 
industrially relevant metabolites. Several approaches are being combined to yield interesting 498 
target compounds, in some cases successfully at industrial level. Rather than focusing on a 499 
specific biosynthetic pathway, the systemic nature and specific features of secondary metabolism 500 
must be considered (Fig. 4). Adequately addressing and taking advantage of the singularities of 501 
plant secondary metabolism, effectively integrating physiological, biochemical, molecular, and 502 
synthetic biology approaches, will be instrumental in making aseptic cultures highly attractive 503 
technologies for producing plant secondary metabolites. 504 
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